Glenmark Pharmaceuticals Ltd

Common Name

Glenmark Pharmaceuticals

Country

India

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

15,800

Ticker

GLENMARK

Exchange

NATIONAL STOCK EXCHANGE OF INDIA

Website

glenmarkpharma.com

Description

Glenmark Pharmaceuticals Ltd. is a global pharmaceutical company that focuses on developing and marketing innovative medicine. With a robust portfolio of both generic and branded pharmaceuticals, Glen... Show more

Financial Statements of Glenmark Pharmaceuticals

Below are the financial statements of Glenmark Pharmaceuticals, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of INR	2025	2024
Non-current assets	—	—
Property, plant and equipment	30,761.59^a	29,190.77^a
Capital work-in-progress	5,419.87^a	4,193.24^a
Right-of-use assets	2,432.07^a	1,990.76^a
Goodwill	702.66^a	673.59^a
Other intangible assets	10,971.93^a	10,246.5^a
Intangible assets under development	2,928.4^a	2,425.56^a
Financial assets	—	—
Investments	563.55^a	7,896.64^a
Other financial assets	729.42^a	698.83^a
Deferred tax assets (net)	11,241.09^a	10,497.22^a
Other non-current assets	1,790.31^a	1,492.31^a
Total non-current assets	67,540.89^a	69,305.42^a
Current assets	—	—
Inventories	30,285.3^a	25,130.51^a
Financial assets	—	—
Trade receivables	33,419.47^a	18,584.12^a
Cash and cash equivalents	16,757.07^a	16,582.7^a
Bank balances other than cash and cash equivalents	295.21^a	11.86^a
Other financial assets	624.46^a	1,735.97^a
Other current assets	11,573.14^a	12,235.66^a
Total current assets	92,954.65^a	74,280.82^a
Total assets	160,495.54^a	143,586.24^a
Equity	—	—
Equity share capital	282.19^a	282.19^a
Other equity	88,212.22^a	78,197.08^a
Equity attributable to owners of Glenmark Pharmaceuticals Limited	88,494.41^a	78,479.27^a
Non-controlling interests	-3.71^a	-3.8^a
Total equity	88,490.7^a	78,475.47^a
Financial liabilities	—	—
Borrowings	5,127^a	0^a
Lease liabilities	1,862.1^a	1,516.91^a
Other non-current financial liabilities	4,759.62^a	5,388.28^a
Non-current liabilities	—	—
Deferred tax liabilities (net)	585.88^a	2.8^a
Other non-current liabilities	0^a	16.91^a
Total non-current liabilities	12,334.6^a	6,924.9^a
Financial liabilities	—	—
Borrowings	16,814.95^a	9,905.96^a
Lease liabilities	922.62^a	886.43^a
Trade payables	—	—
Total outstanding dues of Micro enterprises and Small enterprises	214.41^a	173.32^a
Total outstanding dues of other than Micro enterprises and Small enterprises	25,580.89^a	25,185.93^a
Other current financial liabilities	7,902.82^a	10,269.84^a
Current liabilities	—	—
Other current liabilities	1,989.98^a	2,443.63^a
Provisions	5,960.83^a	6,411.24^a
Current tax liabilities (net)	283.74^a	2,909.52^a
Total current liabilities	59,670.24^a	58,185.87^a
Total liabilities	72,004.84^a	65,110.77^a
Total equity and liabilities	160,495.54^a	143,586.24^a

Verified Sources Behind Glenmark Pharmaceuticals’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Glenmark Pharmaceuticals’s data sources below and access millions more through our Disclosure Search.

a. Glenmark Pharmaceuticals's Integrated Report 2025

Trace every data point back to Glenmark Pharmaceuticals’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Glenmark Pharmaceuticals Ltd

Financial Statements of Glenmark Pharmaceuticals

Verified Sources Behind Glenmark Pharmaceuticals’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Dr Reddy's Laboratories Ltd

Ajanta Pharma Ltd

Abbott India Ltd

Mankind Pharma Ltd

Lupin Ltd

Divi's Laboratories Ltd